Dr. Deirdre Nolfi

Ramasubramanian (“Ram”) Kalpatthi, MD, is Clinical Research Director of Pediatric Sickle Cell Research and Director of PHO Medical Student and Resident Education at UPMC Children's Hospital of Pittsburgh. He is also a Visiting Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology. He earned his medical degree from Thanjavur Medical College in Thanjavur, India. He completed a Residency at All India Institute of Medical Sciences and Lincoln Medical Center followed by a fellowship at Nationwide Children's Hospital. Dr. Kalpatthi is nationally recognized for his excellence in the clinical care, clinical research, program development and leadership in the field of pediatric hematology oncology with special emphasis on sickle cell disease (SCD) and immune thrombocytopenia (ITP). His other clinical interests include therapeutic apheresis, immune hematological disorders, neonatal hematology, benign hematological disorders, and childhood leukemia. Also, he is a favorite among medical students, residents, and fellows due to his passion for teaching, guiding, and mentoring future generation of physicians. He has mentored medical students, residents, and fellows in completing clinical research projects that have been published and/or presented at national conferences such as the American Society of Hematology (ASH), the American Society of Pediatric Hematology/Oncology (ASPHO) and Pediatric Academic Societies (PAS) meeting. Several of his mentees received outstanding abstract achievement awards for their work and most of his mentees have published their research in leading medical journals. View the full list of Dr. Kalpatthi’s publications on PubMed. Dr. Kalpatthi is rated as an Experienced provider by MediFind in Splenectomy. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.

Jean M. Tersak, MD, provides care for pediatric oncology patients and long term survivors of childhood cancer at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is institutional principal investigator for the UPMC Children’s Oncology Group and director of clinical oncology research within the Division of Pediatric Hematology/Oncology. She is also a professor of pediatrics and clinical and translational science at the University of Pittsburgh School of Medicine and is board-certified in pediatric hematology/oncology. Dr. Tersak earned her bachelor's degree, master’s degree, and  medical degree from the University of Pittsburgh. She completed her residency and fellowship at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis. Her research interests include the late effects, quality of life, and neurocognitive outcomes in survivors of childhood cancer and evaluation and treatment of opsoclonus myoclonus in patients with neuroblastoma. She is a member of the American Society of Clinical Oncology Children’s Oncology Group. View the full list of Dr. Tersak’s publications on PubMed. Dr. Tersak is rated as an Advanced provider by MediFind in Splenectomy. Her top areas of expertise are Neuroepithelioma, Neuroblastoma, Histiocytosis, Bone Marrow Aspiration, and Splenectomy.